HEGP
Paris, 75015, France
NCT Number: NCT07313085
In order to clarify the mechanism of fecal incontinence in in Wolfram syndrome and to characterize its risk factors, the examiner will reviewed the files of patients followed in a Reference Center for Rare Diseases in Ophthalmology.
Trial opening soon.
Get NotifiedAll sexes
Observational
Paris, 75015, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
retrospective analysis of data
Time frame: The date at the baseline
number of patients with urinary disorder in each group according to the group
Time frame: The date the data will be analyzed at the baseline
number of patients with sleep apnea in each group according to the group
Time frame: The data will be analyzed at baseline
number of patients with swallowing disorders in each group according to the group
Time frame: The data will be analyzed at baseline
number of patients with diabetes insipidus in each group according to the group
Time frame: The data will be analyzed at baseline
report of mutations of WFS1 in each group
Contact information is provided by the study sponsor or research team.
Hôpital Necker-Enfants Malades
Other
Physiopathogenic Mechanisms of Fecal Incontinence in Wolfram Syndrome
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03717909
Abnormalities, Multiple, Blindness
Montpellier, France
View Trial DetailsNCT05676034
Abnormalities, Multiple, Blindness
St Louis, Missouri, United States
View Trial DetailsNCT02841553
Abnormalities, Multiple, Ataxia
St Louis, Missouri, United States
View Trial DetailsNCT03988764
Abnormalities, Multiple, Autoimmune Diseases
Montreal, Quebec, Canada
View Trial Details